oseltamivir has been researched along with Lupus Nephritis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Bruner, E; Gilkeson, G; Molano, I; Nowling, TK; Rodgers, J; Sundararaj, K; Thiyagarajan, T; Wolf, B | 1 |
Akyollu, B; Arpali, E; Kocak, B; Tekin, S; Turkmen, A; Yelken, B | 1 |
2 other study(ies) available for oseltamivir and Lupus Nephritis
Article | Year |
---|---|
Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice.
Topics: Animals; Ceramides; Female; G(M3) Ganglioside; Glycosphingolipids; Kidney; Lactosylceramides; Lupus Nephritis; Mice; Mice, Inbred MRL lpr; Neuraminidase; Oseltamivir; Phosphorous Acids; Pilot Projects; Proteinuria | 2020 |
Case report: A kidney transplant patient with mild COVID-19.
Topics: Adult; Antiviral Agents; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Treatment; Disease Management; Female; Fever; Glucocorticoids; Graft Rejection; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Lupus Nephritis; Oseltamivir; Pandemics; Pneumonia, Viral; Prednisone; SARS-CoV-2; Severity of Illness Index; Tacrolimus | 2020 |